SUNPHARMA Q4 FY26 Guidance vs Delivery (SUNPHARMA Management Mirror)

Did SUNPHARMA's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

  • SUNPHARMA Financials
  • SUNPHARMA Shareholding Pattern
  • SUNPHARMA Earnings Documents
  • SUNPHARMA Announcements
  • SUNPHARMA Corporate Actions
  • SUNPHARMA Bulk, Block & Insider Deals
  • SUNPHARMA Delivery Data
  • SUNPHARMA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q4FY26 Management Mirror - Mar-2026 Qtr

Revenue Growth

In the Mar'26 Qtr, management established a new target for consolidated top-line growth in the high single digits for FY27. [Status: Initiated]

5 more themes on the ELITE plan.

  • SUNPHARMA Q4FY26 Concall Summary
  • SUNPHARMA Q4FY26 Concall Transcript
  • SUNPHARMA Q3FY26 Management Mirror (Dec-2025 Qtr)
  • SUNPHARMA Q1FY27 Management Mirror (Jun-2026 Qtr)